MedPath

Norwegian Stoma Trial

Recruiting
Conditions
Complication,Postoperative
Rectal Cancer
Quality of Life
Ileostomy; Complications
Interventions
Procedure: Rectal resection with diverting stoma
Procedure: Rectal resection with permanent colostomy
Procedure: Rectal resection without diverting stoma
Registration Number
NCT05243771
Lead Sponsor
The Hospital of Vestfold
Brief Summary

The Norwegian Stoma Trial is an open-label multicenter trial investigating the use of stomas, both diveriting and permanent, in the surgical treatment of rectal cancer. The objective is to compare the chosen strategy to surgical complications, health realted quality of life and length of stay.

Detailed Description

In this national, multicenter study the study group will investigate whether patients with rectal adenocarcinoma undergoing a resection with an anastomosis will benefit from a diverting stoma or not, by studying how choice of surgery affects complications. In addition the study group will investigate complication rates and HRQoL among patients receiving a permanent colostomy and compare this to patients who have received an anastomosis. The investigators know that there are different approaches to the use of stomas (both permanent and diverting) between different hospitals. The investigators aim to discover potential differences in complication rates, length of stay and HRQoL among these patients and compare this to the chosen strategy. Health related quality of life will be measured using the EORTC CR 29 and EORTC CR 30 questionnares. Bowel function will also be monitored using the LARS (low anterior resection syndrome) score.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Age 18 years or older
  • Verified rectal adenocarcinoma by biopsy
  • Tumor located in the rectum with lower border of the tumor located 15 cm or less from the anal verge.
  • Given informed consent
Exclusion Criteria
  • Advanced tumor stage requiring exenterative surgery beyond a convetional APR or TME.
  • Stage IV disease
  • Synchronous colon cancer necessitating a total colectomy
  • Other concomitant disease(s) which will complicate participation.
  • Unwillingness to give informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Rectal resection with diverting stomaRectal resection with diverting stomaPatients operated for rectal cancer with rectal resection and diverting stoma.
Rectal resection with primary colostomyRectal resection with permanent colostomyPatients operated for rectal cancer with rectal resection with primary colostomy.
Rectal resection without diverting stomaRectal resection without diverting stomaPatients operated for rectal cancer with rectal resection without diverting stoma.
Primary Outcome Measures
NameTimeMethod
Surgical complications graded as Accordion grade 3 or moreMeasured one year after the primary surgery

The study group will investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have higher complication rates compared to patients who do not recieve a diverting stoma.

Secondary Outcome Measures
NameTimeMethod
Total length of hospital stayMeasured one year after the primary surgery

Number of days admitted at hospital. The study group will investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have a higher number of days admitted to hospital compared to patients who do not recieve a diverting stoma.

Bowel function measured by the Low Anterior Resection Syndrome (LARS) scoreOne year after the primary surgery

Bowel function is measured using the Low Anterior Resection Syndrome score. The score ranges from 0 to 42 points The higher the score, the worse the bowel function. Investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have higher LARS scores compared to patients who do not recieve a diverting stoma.

Surgical complications graded as Accordion grade 3 or moreMeasured one year after the primary surgery

Investigate whether patients receiving a rectal resection with a primary colostomy have lower complication rates compared to patients receiving an anastomosis

Generic health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) C30 questionnaireOne year after the primary surgery

Generic health related quality of life is measured using the EORTC C30 questionnaire. Investigate whether patients receiving a rectal resection with a primary colostomy have poorer health related quality of life compared to patients receiving an anastomosis.

Generic health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) C30 questionnaire.One year after the primary surgery

Generic health related quality of life is measured using the EORTC C30 questionnaire. Investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have poorer health related quality of life compared to patients who do not recieve a diverting stoma.

Disease specific health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) CR29 questionnnaireOne year after the primary surgery

Disease specific health related quality of life measured by the EORTC CR29 questionnnaire. Investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have poorer health related quality of life compared to patients who do not recieve a diverting stoma.

Disease specific health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) CR29 questionnnaire.One year after the primary surgery

Disease specific health related quality of life measured by the EORTC CR29 questionnnaire. Investigate whether patients receiving a rectal resection with a primary colostomy have poorer health related quality of life compared to patients receiving an anastomosis.

Trial Locations

Locations (18)

Vestfold Hospital Trust

🇳🇴

Tønsberg, Norway

St. Olavs Hospital

🇳🇴

Trondheim, Norway

Ålesund Hospital

🇳🇴

Ålesund, Norway

Haukeland University Hospital

🇳🇴

Bergen, Norway

Vestre Viken Hospital Trust

🇳🇴

Drammen, Norway

Bodø Hospital

🇳🇴

Bodø, Norway

Østfold Hospital Trust

🇳🇴

Sarpsborg, Grålum, Norway

Akershus University Hospital

🇳🇴

Oslo, Lørenskog, Norway

Hamar Hospital

🇳🇴

Hamar, Norway

Helse Fonna

🇳🇴

Haugesund, Norway

Helse Nord-Trøndelag HF

🇳🇴

Levanger, Norway

Ullevaal University Hospital

🇳🇴

Oslo, Norway

Helse Stavanger HF

🇳🇴

Stavanger, Norway

Sykehuset Telemark

🇳🇴

Skien, Norway

University Hospital of North Norway

🇳🇴

Tromsø, Norway

Sorlandet Hospital HF

🇳🇴

Kristiansand, Norway

Asker og Baerum Hospital

🇳🇴

Bærums Verk, Gjettum, Norway

Gjøvik Hospital

🇳🇴

Gjøvik, Norway

© Copyright 2025. All Rights Reserved by MedPath